Skip to main content

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

GBT holding history

Global Blood Therapeutics, Inc. in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GBT overviewAll 13F holders of GBTFull Q2 2026 holdings

Shares (Q4 2022)
0
Sold out in Q4 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2022
Holdings of GBT by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20220$00.0%−58−100.0%Sold outHolders
Q3 202258$3.95K<0.1%+58NewHolders